133
Views
15
CrossRef citations to date
0
Altmetric
Original Research

In vitro comparison of liposomal drug delivery systems targeting the oxytocin receptor: a potential novel treatment for obstetric complications

&
Pages 2191-2206 | Published online: 27 Mar 2019

References

  • ButwickAJCarvalhoBBlumenfeldYJEl-SayedYYNelsonLMBatemanBTSecond-line uterotonics and the risk of hemorrhage-related morbidityAm J Obstet Gynecol20152125642.e1642.e725582104
  • de HeusRMolBWErwichJJAdverse drug reactions to tocolytic treatment for preterm labour: prospective cohort studyBMJ2009338b74419264820
  • HaasDMCaldwellDMKirkpatrickPMcintoshJJWeltonNJTocolytic therapy for preterm delivery: systematic review and network meta-analysisBMJ2012345e622623048010
  • JørgensenJSWeileLKLamontRFPreterm labor: current tocolytic options for the treatment of preterm laborExpert Opin Pharmacother201415558558824456411
  • MousaHABlumJAbou El SenounGShakurHAlfirevicZTreatment for primary postpartum haemorrhageCochrane Database Syst Rev20142CD003249
  • LiuLOzaSHoganDGlobal, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysisLancet2015385996643044025280870
  • ManuckTARiceMMBailitJLPreterm neonatal morbidity and mortality by gestational age: a contemporary cohortAm J Obstet Gynecol20162151103.e1103.e1426772790
  • RomeroRDeySKFisherSJPreterm labor: one syndrome, many causesScience2014345619876076525124429
  • Al-ZirqiIVangenSForsenLStray-PedersenBPrevalence and risk factors of severe obstetric haemorrhageBJOG2008115101265127218715412
  • KhanKSWojdylaDSayLGülmezogluAMvan LookPFWho analysis of causes of maternal death: a systematic reviewLancet200636795161066107416581405
  • ArrowsmithSWraySOxytocin: its mechanism of action and receptor signalling in the myometriumJ Neuroendocrinol201426635636924888645
  • BlanchGLavenderTWalkinshawSAlfirevicZDysfunctional labour: a randomised trialBr J Obstet Gynaecol199810511171209442174
  • ArrowsmithSKendrickAWraySDrugs acting on the pregnant uterusObstet Gynaecol Reprod Med201020824124724443652
  • GoodwinTMPaulRSilverHThe effect of the oxytocin antagonist atosiban on preterm uterine activity in the humanAm J Obstet Gynecol199417024744788116700
  • RomeroRSibaiBMSanchez-RamosLAn oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescueAm J Obstet Gynecol200018251173118310819855
  • WathesDCBorwickSCTimmonsPMLeungSTThorntonSOxytocin receptor expression in human term and preterm gestational tissues prior to and following the onset of labourJ Endocrinol1999161114315110194538
  • FuchsARFuchsFHussleinPSoloffMSOxytocin receptors in the human uterus during pregnancy and parturitionAm J Obstet Gynecol198415067347416093538
  • FuchsARFieldsMJFreidmanSShemeshMIvellROxytocin and the timing of parturition. Influence of oxytocin receptor gene expression, oxytocin secretion, and oxytocin-induced prostaglandin F2 alpha and E2 releaseAdv Exp Med Biol19953954054208713995
  • KimuraTTakemuraMNomuraSExpression of oxytocin receptor in human pregnant myometriumEndocrinology199613727807858593830
  • AkerlundMTargeting the oxytocin receptor to relax the myometriumExpert Opin Ther Targets200610342342716706682
  • PaulJWHuaSIlicicMDrug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptorAm J Obstet Gynecol20172163283.e1283.e1427567564
  • HuaSSynthesis and in vitro characterization of oxytocin receptor targeted PEGylated immunoliposomes for drug delivery to the uterusJ Liposome Res2019111
  • SercombeLVeeratiTMoheimaniFWuSYSoodAKHuaSAdvances and challenges of liposome assisted drug deliveryFront Pharmacol2015628626648870
  • UlrichASBiophysical aspects of using liposomes as delivery vehiclesBiosci Rep200222212915012428898
  • MajumderPBhuniaSBhattacharyyaJChaudhuriAInhibiting tumor growth by targeting liposomally encapsulated CDC20siRNA to tumor vasculature: therapeutic RNA interferenceJ Control Release201418010010824556418
  • ReddyJAAbburiCHoflandHFolate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumorsGene Ther20029221542155012407426
  • HuaSChangHIDaviesNMCabotPJTargeting of ICAM-1-directed immunoliposomes specifically to activated endothelial cells with low cellular uptake: use of an optimized procedure for the coupling of low concentrations of antibody to liposomesJ Liposome Res20112129510520429814
  • Lopes de MenezesDEPilarskiLMAllenTMIn vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphomaCancer Res19985815332033309699662
  • VoineaMManduteanuIDragomirECapraruMSimionescuMImmunoliposomes directed toward VCAM-1 interact specifically with activated endothelial cells-a potential tool for specific drug deliveryPharm Res200522111906191716088429
  • EvertsMKoningGAKokRJIn vitro cellular handling and in vivo targeting of E-selectin-directed immunoconjugates and immunoliposomes used for drug delivery to inflamed endotheliumPharm Res2003201647212608538
  • ZinggHHLaporteSAThe oxytocin receptorTrends Endocrinol Metab200314522222712826328
  • SzukiewiczDBilskaAMittalTKMyometrial contractility influences oxytocin receptor (OXTR) expression in term trophoblast cells obtained from the maternal surface of the human placentaBMC Pregnancy Childbirth20151522026377392
  • GimplGFahrenholzFThe oxytocin receptor system: structure, function, and regulationPhysiol Rev200181262968311274341
  • TakemuraMKimuraTNomuraSExpression and localization of human oxytocin receptor mRNA and its protein in chorion and decidua during parturitionJ Clin Invest1994936231923238200965
  • AnabousiSLaueMLehrC-MBakowskyUEhrhardtCAssessing trans-ferrin modification of liposomes by atomic force microscopy and transmission electron microscopyEur J Pharm Biopharm200560229530315939240
  • BendasGKrauseABakowskyUVogelJRotheUTargetability of novel immunoliposomes prepared by a new antibody conjugation techniqueInt J Pharm19991811799310370205
  • SharkeyJOlceseJTranscriptional inhibition of oxytocin receptor expression in human myometrial cells by melatonin involves protein kinase C signalingJ Clin Endocrinol Metab200792104015401917726073
  • SoloffMSJengYJIliesMImmortalization and characterization of human myometrial cells from term-pregnant patients using a telomerase expression vectorMol Hum Reprod200410968569515243128
  • MaggiMPeriABaldiEInterferon-alpha downregulates expression of the oxytocin receptor in cultured human myometrial cellsAm J Physiol19962715 Pt 1E840E8468944670
  • TaharaATsukadaJTomuraYPharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cellsBr J Pharmacol2000129113113910694212
  • BusnelliMRimoldiVViganòPPersaniLDi BlasioAMChiniBOxytocin-induced cell growth proliferation in human myometrial cells and leiomyomasFertil Steril20109451869187420056210
  • MolnárMRigoJJrRomeroRHertelendyFOxytocin activates mitogen-activated protein kinase and up-regulates cyclooxygenase-2 and prostaglandin production in human myometrial cellsAm J Obstet Gynecol19991811424910411794
  • OhmichiMKoikeKNoharaAOxytocin stimulates mitogen-activated protein kinase activity in cultured human puerperal uterine myometrial cellsEndocrinology19951365208220877536662
  • PhaneufSEurope-FinnerGNVarneyMMackenzieIZWatsonSPLópez BernalAOxytocin-stimulated phosphoinositide hydrolysis in human myometrial cells: involvement of pertussis toxin-sensitive and -insensitive G-proteinsJ Endocrinol199313634975098386215
  • JengYJSoloffSLAndersonGDSoloffMSRegulation of oxyto-cin receptor expression in cultured human myometrial cells by fetal bovine serum and lysophospholipidsEndocrinology20031441616812488330
  • RefuerzoJSLeonardFBulayevaNUterus-targeted liposomes for preterm labor management: studies in pregnant miceSci Rep201663471027725717
  • VrachnisNMalamasFMSifakisSDeligeoroglouEIliodromitiZThe oxytocin-oxytocin receptor system and its antagonists as tocolytic agentsInt J Endocrinol2011201135054622190926
  • PlestedCPBernalALDesensitisation of the oxytocin receptor and other G-protein coupled receptors in the human myometriumExp Physiol200186230331211429648
  • PhaneufSRodríguez LiñaresBTambyrajaRLMackenzieIZLópez BernalALoss of myometrial oxytocin receptors during oxytocin-induced and oxytocin-augmented labourJ Reprod Fertil20001201919711006150
  • OakleyRHLaporteSAHoltJABarakLSCaronMGMolecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*J Biol Chem200127622194521946011279203
  • GimplGBurgerKPolitowskaECiarkowskiJFahrenholzFOxytocin receptors and cholesterol: interaction and regulationExp Physiol200085 Spec No:41S-49S
  • GimplGFahrenholzFHuman oxytocin receptors in cholesterol-rich vs cholesterol-poor microdomains of the plasma membraneEur J Biochem200026792483249710785367
  • VercauterenDVandenbrouckeREJonesATThe use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfallsMol Ther201018356156920010917
  • AndersonMOmriAThe effect of different lipid components on the in vitro stability and release kinetics of liposome formulationsDrug Deliv2004111333915168789
  • AllenTMLong-circulating (sterically stabilized) liposomes for targeted drug deliveryTrends Pharmacol Sci19941572152207940982
  • TorchilinVPImmunoliposomes and PEGylated immunoliposomes: possible use for targeted delivery of imaging agentsImmunomethods1994432442587820455
  • NormanJEBollapragadaSYuanMNelsonSMInflammatory pathways in the mechanism of parturitionBMC Pregnancy Childbirth20077Suppl 1S717570167
  • HuaSde MatosMBCMetselaarJMStormGCurrent trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and CommercializationFront Pharmacol2018979030065653
  • ShojoHKanekoYCharacterization and expression of oxytocin and the oxytocin receptorMol Genet Metab200071455255811136546
  • BossmarTAkerlundMFantoniGSzamatowiczJMelinPMaggiMReceptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist atosibanAm J Obstet Gynecol19941716163416427802081
  • MaggiMDel CarloPFantoniGHuman myometrium during pregnancy contains and responds to V1 vasopressin receptors as well as oxytocin receptorsJ Clin Endocrinol Metab1990704114211542156888
  • CassoniPSapinoAFortunatiNMunaronLChiniBBussolatiGOxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase AInt J Cancer19977223403449219843
  • ItoYKobayashiTKimuraTInvestigation of the oxytocin receptor expression in human breast cancer tissue using newly established monoclonal antibodiesEndocrinology199613727737798593829
  • LeeKHKhan-DawoodFSDawoodMYOxytocin receptor and its messenger ribonucleic acid in human leiomyoma and myometriumAm J Obstet Gynecol19981793 Pt 16206279757961
  • CassoniPFulcheriECarcangiuMLStellaADeaglioSBussolatiGOxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significanceJ Pathol2000190447047710699997
  • CassoniPSapinoAStellaAFortunatiNBussolatiGPresence and significance of oxytocin receptors in human neuroblastomas and glial tumorsInt J Cancer19987756957009688301